<VariationArchive VariationID="1453748" VariationName="NM_024753.5(TTC21B):c.2482dup (p.Met828fs)" VariationType="Duplication" Accession="VCV001453748" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1451274" VariationID="1453748">
      <GeneList>
        <Gene Symbol="TTC21B" FullName="tetratricopeptide repeat domain 21B" GeneID="79809" HGNC_ID="HGNC:25660" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165873362" stop="165953776" display_start="165873362" display_stop="165953776" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166729871" stop="166810347" display_start="166729871" display_stop="166810347" Strand="-" />
          </Location>
          <OMIM>612014</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024753.5(TTC21B):c.2482dup (p.Met828fs)</Name>
      <CanonicalSPDI>NC_000002.12:165907763:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165907763" stop="165907764" display_start="165907763" display_stop="165907764" variantLength="1" positionVCF="165907763" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166764273" stop="166764274" display_start="166764273" display_stop="166764274" variantLength="1" positionVCF="166764273" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>M828fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.166764274dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.166764274dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.165907764dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.165907764dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_030345.1" sequenceAccession="NG_030345" sequenceVersion="1" change="g.51075dup">
            <Expression>NG_030345.1:g.51075dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024753.5" sequenceAccession="NM_024753" sequenceVersion="5" change="c.2482dup" MANESelect="true">
            <Expression>NM_024753.5:c.2482dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079029.3" sequenceAccession="NP_079029" sequenceVersion="3" change="p.Met828fs">
            <Expression>NP_079029.3:p.Met828fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="906032090" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00003" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024753.5(TTC21B):c.2482dup (p.Met828fs) AND multiple conditions" Accession="RCV001941520" Version="3">
        <ClassifiedConditionList TraitSetID="22843">
          <ClassifiedCondition DB="MedGen" ID="C0265275">Jeune thoracic dystrophy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024753.5(TTC21B):c.2482dup (p.Met828fs) AND multiple conditions" Accession="RCV002479576" Version="1">
        <ClassifiedConditionList TraitSetID="10165">
          <ClassifiedCondition DB="MedGen" ID="C3151185">Asphyxiating thoracic dystrophy 4</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3151186">Nephronophthisis 12</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-15" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18327258</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21068128</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21258341</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23559409</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25492405</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27491411</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29068549</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="22843" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="455" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Jeune syndrome</ElementValue>
                <XRef ID="MONDO:0018770" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile thoracic dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic pelvic phalangeal dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Jeune's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chondroectodermal dysplasia-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Short-rib thoracic dysplasia</ElementValue>
                <XRef Type="Phenotypic series" ID="PS208500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Jeune thoracic dystrophy</ElementValue>
                <XRef ID="75049004" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ATD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ATD1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3049" />
                <XRef ID="3049" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="474" DB="Orphanet" />
              <XRef ID="C0265275" DB="MedGen" />
              <XRef ID="MONDO:0018770" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS208500" DB="OMIM" />
            </Trait>
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10165" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16083" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 12</ElementValue>
                <XRef ID="Nephronophthisis+12/8980" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013442" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP12</ElementValue>
                <XRef Type="MIM" ID="613820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TTC21B</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Classic Joubert syndrome (JS) is characterized by three primary findings: A distinctive cerebellar and brain stem malformation called the molar tooth sign (MTS). Hypotonia. Developmental delays. Often these findings are accompanied by episodic tachypnea or apnea and/or atypical eye movements. In general, the breathing abnormalities improve with age, truncal ataxia develops over time, and acquisition of gross motor milestones is delayed. Cognitive abilities are variable, ranging from severe intellectual disability to normal. Additional findings can include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. Both intra- and interfamilial variation are seen.</Attribute>
                <XRef ID="NBK1325" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301500</ID>
                <ID Source="BookShelf">NBK1325</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C3151186" DB="MedGen" />
              <XRef ID="MONDO:0013442" DB="MONDO" />
              <XRef Type="MIM" ID="613820" DB="OMIM" />
            </Trait>
            <Trait ID="16018" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY</ElementValue>
                <XRef Type="MIM" ID="613819" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Asphyxiating thoracic dystrophy 4</ElementValue>
                <XRef ID="Asphyxiating+thoracic+dystrophy+4/7719" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013441" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SHORT-RIB THORACIC DYSPLASIA 4</ElementValue>
                <XRef Type="Allelic variant" ID="612014.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="612014.0005" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SRTD4</ElementValue>
                <XRef Type="MIM" ID="613819" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATD4</ElementValue>
                <XRef Type="MIM" ID="613819" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15718" />
                <XRef ID="15718" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="474" DB="Orphanet" />
              <XRef ID="C3151185" DB="MedGen" />
              <XRef ID="MONDO:0013441" DB="MONDO" />
              <XRef Type="MIM" ID="613819" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5450295" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_024753.5:c.2482dup|OMIM:613819;613820" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002799785" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024753.5:c.2482dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613819" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613820" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4248767" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="579487|MedGen:C0265275;C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002236709" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18327258</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21068128</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21258341</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24876116</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25492405</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27491411</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29068549</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Met828Asnfs*15) in the TTC21B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TTC21B are known to be pathogenic (PMID: 18327258, 21068128, 21258341, 23559409, 24876116, 25492405, 27491411, 29068549). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with TTC21B-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TTC21B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.166764273_166764274insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265275" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5450295" TraitType="Disease" MappingType="XRef" MappingValue="613820" MappingRef="OMIM">
        <MedGen CUI="C3151186" Name="Nephronophthisis 12" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4248767" TraitType="Disease" MappingType="XRef" MappingValue="C0265275" MappingRef="MedGen">
        <MedGen CUI="C0265275" Name="Jeune thoracic dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4248767" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5450295" TraitType="Disease" MappingType="XRef" MappingValue="613819" MappingRef="OMIM">
        <MedGen CUI="C3151185" Name="Asphyxiating thoracic dystrophy 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

